Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8791149
Methods of treating traumatic brain injury using pro-neurogenic compounds
granted -
US 8784881
Liposomal curcumin for treatment of diseases
granted -
US 8784866
Water-soluble carbon nanotube compositions for drug delivery and medicinal applications
granted -
US 8785409
Compounds having anti-adhesive effects on cancer cells
granted -
US 8785483
Methods for treating COPD
granted -
US 8785514
Dual-cure dental resins and adhesives with increased cure and color stability and low color
granted -
US 8785499
Targeting NAD biosynthesis in bacterial pathogens
granted -
US 8779151
Orally bioavailable caffeic acid related anticancer drugs
granted -
US 8779094
Low viscosity highly concentrated suspensions
granted -
US 8778940
Chemical inducers of neurogenesis
granted -
US 8778343
Antibodies that bind tau oligomers
granted -
US 8778876
Small-molecule inhibitors of Dengue and West Nile virus proteases
granted -
US 8771965
Methods and compositions involving nucleotide repeat disorders
granted -
US 8771713
Method and process for the production of multi-coated recognitive and releasing systems
granted -
US 8765797
TG2 inhibitors and uses thereof
granted -
US 8758723
Compositions and methods for cellular imaging and therapy
granted -
US 8754124
Oligo-benzamide compounds and their use in treating cancers
granted -
US 8747843
Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor
granted -
US 8748473
Methods of treating post-traumatic stress disorder using pro-neurogenic compounds
granted -
US 8748591
Chimeric sindbis-western equine encephalitis virus and uses thereof
granted -
US 8741316
Highly porous, recognitive polymer systems
granted -
US 8735440
Methods for treating amyotrophic lateral sclerosis using pro-neurogenic compounds
granted -
US 8735066
Tumor suppressor designated TS10Q23.3
granted -
US 8734853
HDL particles for delivery of nucleic acids
granted